Liraglutide exemplifies this approach through specific molecular modifications
Beyond these major organs, the receptor turns up on cells of the immune system, including macrophages, lymphocytes, and invariant natural killer T cells, where it appears to exert anti-inflammatory effects
Consequently, in the forthcoming period, it is imperative to conduct in-depth investigations into the specific molecular mechanisms underlying the anti-inflammatory and immunomodulatory properties of GLP-1RAs in psoriasis
It may look like a compact disc, a fluffy cake, or loose powder
As a negative control, we treated the HAP with only 100 nM cilostamide
GLP-1RAs have now become a part of an emerging treatment approach for obesity, with liraglutide being the first GLP-1RA approved by the US Food and Drug Administration (FDA) in December 2014